Presentation Information
[2P-750]Clonal landscape of autoantibody production in severe COVID-19
○Shuhei Sakakibara1,2, Yu-Chen Liu1, Masakazu Ishikawa1,3, Ryuya Edahiro1,4,5, Yuya Shirai1,4,5, Xu Zichang1, Songling Li1,6, Yuta Yamaguchi1,4, Teruaki Murakami1,4, Takayoshi Morita1,4, Yasuhiro Kato1,4, Haruhiko Hirata4, Yoshito Takeda4, Fuminori Sugihara1, Daisuke Motooka6, James B Wing1,7, Hisatake Matsumoto3,8, Hiroshi Ogura8, Atsushi Kumanogoh1,3,4,7,9, Yukinari Okada1,3,5,7,9,10,11, Daron M Standley1,3,6,7, Hitoshi Kikutani1, Daisuke Okuzaki1,3,6,7 (1. Immunology Frontier Research Center, Osaka Univ., 2. Jikei University of Health Care Sciences, 3. Center for Infectious Disease Education and Research, Osaka Univ., 4. Dept. of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka Univ. , 5. Dept. of Statistical Genetics, Graduate School of Medicine, Osaka Univ. , 6. Research Institute for Microbial Diseases, Osaka Univ., 7. Center for Advanced Modalities and DDS, Osaka Univ., 8. Dept. of Traumatology and Acute Critical Medicine, Graduate School of Medicine, Osaka Univ. , 9. Integrated Frontier Research for Medical Science Division, Osaka Univ., 10. Dept. of Genome Informatics, Graduate School of Medicine, The Univ. of Tokyo , 11. Riken Center for Integrated Medical Sciences)
Password required to view
orLog in
Comment
To browse or post comments, you must log in.Log in